Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
1.03
0.07 (7.63%)
At close: Aug 22, 2025, 3:59 PM
1.03
0.02%
After-hours: Aug 22, 2025, 07:46 PM EDT

Ovid Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.68M -10.23M -9.25M -14.01M 8.52M -11.69M -15.32M -11.25M -12.41M -13.36M -11.5M -11.97M -14.59M -16.11M -26M -11.38M -15.79M 176.01M
Depreciation & Amortization
99K 141K 160K 169K 148K 136K 401.39K 402.46K 394.76K 398K 439.95K 415.37K 452.48K 73.81K 56.95K 52.18K 53.22K 74.73K
Stock-Based Compensation
1.22M 1.28M 1.26M 1.31M 1.74M 1.97M 1.79M 1.63M 1.95M 1.92M 1.73M 1.78M 1.72M 1.32M 1.32M 1.16M 1.26M 1.32M
Other Working Capital
-3.25M -61K -1.33M 265K 3.06M -1.63M 1.17M 2.58M -2.96M -149K -985.99K 1.22M -3.84M 557.43K 1.34M -2.94M -2.7M -14.23M
Other Non-Cash Items
-164K -167K -1.32M -30K -27.73M -5.36M -2.33M -1.21M -125.48K -801K 225.64K -538.6K 612.17K -1.06M 7.3M -968.8K 2.58M 12.07M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -105.41K 346.35K -488.09K n/a n/a n/a n/a n/a -0.00 n/a n/a n/a
Change in Working Capital
-1.24M -1.3M -853K -2.45M 3.06M -1.74M 3.65M 28.98K -1.03M -270K -66.15K -2.37M -1.49M -4.31M 5.33M -701.86K -4.94M -16.5M
Operating Cash Flow
-4.77M -10.28M -10.01M -15.01M -14.26M -16.69M -11.91M -10.05M -11.71M -12.11M -9.18M -12.68M -13.29M -20.09M -12M -10.87M -19.42M 160.9M
Capital Expenditures
n/a n/a -22K 4K -34K -19K -1.22K -5.25K -117.43K -14K -63K -18.6K -1.26M -76.17K -161.96K -15.94K n/a -11.51K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 48.5M 4.35M 109.64K n/a 2.5M -2.5M n/a n/a 48.1K -48.1K n/a n/a
Purchase of Investments
-4.95M -4.9M -16.71M -9.71M -37.03M -9.79M -58.51M -29.35M -14.82M -9.76M -64.11M -29.44M -79.42M n/a -1.63M -48.1K -1.58M n/a
Sales Maturities Of Investments
17M 10M 38M 10M 50M 30M 10M 25M 45M 40M 60M 30M n/a n/a 1.59M n/a n/a n/a
Other Investing Acitivies
n/a n/a 27K n/a -116K n/a -48.5M -4.35M -10.11M 1K -2.5M -1.94M -79.64M -1M -3.77K -41.98K -1.58M n/a
Investing Cash Flow
12.05M 5.1M 21.29M 292K 12.82M 20.19M -48.52M -4.36M 20.07M 30.23M -4.17M -1.96M -80.68M -1.08M -161.96K -64.03K -1.58M -11.51K
Debt Repayment
n/a n/a n/a n/a n/a n/a 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -43.6K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a 67K -43.6K 81.63K 109.55K 33.08K 109.18K 549.05K 116.19K 129.66K
Financial Cash Flow
n/a 13K n/a 38K 356K 228K 30.03M 223.72K 211.1K 67K -43.6K 81.63K 109.55K 33.08K 109.18K 549.05K 116.19K 129.66K
Net Cash Flow
7.28M -5.17M 11.28M -14.68M -1.08M 3.73M -30.4M -14.19M 8.57M 18.18M -13.39M -14.56M -93.86M -21.13M -12.05M -10.39M -20.88M 161.02M
Free Cash Flow
-4.77M -10.28M -10M -15M -14.29M -16.7M -11.91M -10.06M -11.82M -12.13M -9.24M -12.69M -14.55M -20.16M -12.16M -10.89M -19.42M 160.89M